On May 29, 2025, Canaccord Genuity analyst Richard Close maintained a Buy rating on Phreesia (PHR) while adjusting the price target. The price target was lowere
Truist has adjusted its price target for Phreesia (PHR), raising it from $34 to $35 while maintaining a Buy rating on the stock. This decision follows Phreesia'
Operator: Good morning, ladies and gentlemen. And welcome to the Phreesia First Quarter Fiscal 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Canaccord has adjusted its price target for Phreesia (PHR), reducing it from $35 to $34, while maintaining a Buy rating on the stock. Despite the recent dip in
Revenue: $115.9 million, an increase of 15% year over year.Average Healthcare Services Clients: 4,411, an increase of 70 from the prior quarter and 346 from th
Phreesia Inc demonstrates robust revenue growth with a significant year-over-year increase.Despite growing revenues, the company faces challenges with operatin
May 28, 2025 / 12:30PM GMTOperator Good morning, ladies and gentlemen, and welcome to the Phreesia first-quarter fiscal 2026 earnings conference call. At this t
Phreesia, Inc. (NYSE: PHR) (”Phreesia”) today announced that it will now release its fiscal first quarter 2026 financial results prior to the open of marke
Significant Reduction in Phreesia Holdings On March 31, 2025, Brown Advisory Inc executed a notable reduction in its holdings of Phreesia Inc, decreasing its po
Summary Phreesia Inc (PHR), a leader in patient activation solutions, has announced that it will release its fiscal first quarter 2026 financial results after m
KeyBanc has adjusted its price target for Phreesia (PHR), reducing it to $28 from the previous $30, yet maintaining an Overweight rating on the stock. As the co
DA Davidson has adjusted its price target for Phreesia (PHR), reducing it from $36 to $34, while maintaining a Buy rating on its shares. This change is part of
Shares of Phreesia Inc (PHR) fell 0.54% in mid-day trading on Mar 22. The stock reached an intraday low of $26.92, before recovering slightly to $27.46, dow
Shares of Phreesia Inc (PHR) surged 2.35% in mid-day trading on Mar 19. The stock reached an intraday high of $27.98, before settling at $27.91, up from its
Phreesia Inc (PHR) showcases robust revenue growth across its service segments in fiscal 2025.Despite increased revenues, Phreesia Inc faces challenges with op
Revenue: $109.7 million in Q4, up 15% year-over-year.Adjusted EBITDA: $16.4 million in Q4, up $19.9 million year-over-year.Adjusted EBITDA Margin: 15% in Q4.Av
Mar 12, 2025 / 09:00PM GMTOperator Good evening, ladies and gentlemen, and welcome to Phreesia's Fourth Quarter Fiscal 2025 Earnings Conference Call. (Operator